{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:25:15Z","timestamp":1780471515563,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.xkme.2022.100534","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T23:58:28Z","timestamp":1660262308000},"page":"100534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mycophenolate Mofetil for Severe IgA Vasculitis Nephropathy in Children: An Observational Study"],"prefix":"10.1016","volume":"4","author":[{"given":"Dmitry","family":"Samsonov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zolotnitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Matloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.xkme.2022.100534_bib1","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/ard.2006.069187","article-title":"Henoch Schonlein purpura in children: an epidemiological study among Dutch paediatricians on incidence and diagnostic criteria","volume":"66","author":"Aalberse","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.xkme.2022.100534_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1651-2227.1988.tb10610.x","article-title":"Epidemiology of Schonlein-Henoch purpura","volume":"77","author":"Nielsen","year":"1988","journal-title":"Acta Paediatr Scand"},{"issue":"11","key":"10.1016\/j.xkme.2022.100534_bib3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/adc.2009.182394","article-title":"Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children","volume":"95","author":"Jauhola","year":"2010","journal-title":"Arch Dis Child"},{"issue":"3-4","key":"10.1016\/j.xkme.2022.100534_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2298\/SARH1104174S","article-title":"Henoch-Schonlein purpura outcome in children: a ten-year clinical study","volume":"139","author":"Spasojevi\u0107-Dimitrijeva","year":"2011","journal-title":"Srp Arh Celok Lek"},{"issue":"6","key":"10.1016\/j.xkme.2022.100534_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00467-011-1827-8","article-title":"Henoch-Schonlein purpura nephritis with nephrotic state in children: predictors of poor outcomes","volume":"26","author":"Wakaki","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2022.100534_bib6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00467-011-1834-9","article-title":"Clinical outcomes in children with Henoch-Schonlein purpura nephritis grade IIIa or IIIb","volume":"26","author":"Xia","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2022.100534_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2215\/CJN.06710810","article-title":"Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy","volume":"6","author":"Davin","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2022.100534_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-009-1230-x","article-title":"Pathogenesis of Henoch-Schonlein purpura nephritis","volume":"25","author":"Lau","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.xkme.2022.100534_bib9","first-page":"241","article-title":"Immunological memory stabilizing autoreactivity","volume":"305","author":"Manz","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.xkme.2022.100534_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1100\/tsw.2007.23","article-title":"Therapy for children with Henoch-schonlein purpura nephritis: a systematic review","volume":"7","author":"Zaffanello","year":"2007","journal-title":"ScientificWorldJournal"},{"issue":"12","key":"10.1016\/j.xkme.2022.100534_bib11","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00467-011-1919-5","article-title":"Cyclosporine A vs. methylprednisolone for Henoch-Schonlein nephritis: a randomized trial","volume":"26","author":"Jauhola","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2022.100534_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00467-010-1741-5","article-title":"Treatment strategies for Henoch-Schonlein purpura nephritis by histological and clinical severity","volume":"26","author":"Ninchoji","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2022.100534_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00467-003-1315-x","article-title":"Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide","volume":"19","author":"Tarshish","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2022.100534_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3899\/jrheum.100130","article-title":"Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis","volume":"38","author":"Touma","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.xkme.2022.100534_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00467-011-1859-0","article-title":"New developments in the treatment of systemic lupus erythematosus","volume":"27","author":"Tullus","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2022.100534_bib16","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/ar3835","article-title":"Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus","volume":"14","author":"Eickenberg","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.xkme.2022.100534_bib17","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1523-1755.2004.00588.x","article-title":"Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study","volume":"65","author":"Maes","year":"2004","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.xkme.2022.100534_bib18","first-page":"780","article-title":"Mycophenolate mofetil in the treatment of IgA nephropathy: a systematic review","volume":"49","author":"Tan","year":"2008","journal-title":"Singapore Med J"},{"issue":"6","key":"10.1016\/j.xkme.2022.100534_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ki.2009.499","article-title":"Long-term study of mycophenolate mofetil treatment in IgA nephropathy","volume":"77","author":"Tang","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2022.100534_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000168483","article-title":"Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis","volume":"29","author":"Xu","year":"2009","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2022.100534_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/00365590701571514","article-title":"Mycophenolate mofetil treatment of crescentic Henoch-Schonlein nephritis with IgA depositions","volume":"42","author":"Dede","year":"2008","journal-title":"Scand J Urol Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2022.100534_bib22","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1097\/MJT.0b013e3181b0a713","article-title":"Rapidly progressing glomerulonephritis secondary to Henoch-schonlein purpura treated with mycophenolate mofetil: a case report with atypical etiology and presentation","volume":"17","author":"Muzaffar","year":"2010","journal-title":"Am J Ther"},{"key":"10.1016\/j.xkme.2022.100534_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/254316","article-title":"Treatment of complicated Henoch-schonlein purpura with mycophenolate mofetil: a retrospective case series report","volume":"2010","author":"Nikibakhsh","year":"2010","journal-title":"Int J Rheumatol"},{"issue":"5","key":"10.1016\/j.xkme.2022.100534_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00467-011-2057-9","article-title":"Treatment of children with Henoch-Schonlein purpura nephritis with mycophenolate mofetil","volume":"27","author":"Du","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.xkme.2022.100534_bib25","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.12659\/MSM.904206","article-title":"Evaluation of mycophenolate mofetil and low-dose steroid combined therapy in moderately severe Henoch-Schonlein purpura nephritis","volume":"23","author":"Lu","year":"2017","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.xkme.2022.100534_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00467-017-3846-6","article-title":"Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schonlein purpura nephritis: the role of early initiation and therapeutic drug monitoring","volume":"33","author":"Hackl","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2022.100534_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ki.2012.169","article-title":"Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C","volume":"82","author":"Schwartz","year":"2012","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.xkme.2022.100534_bib28","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2215\/CJN.01640309","article-title":"Measurement and estimation of GFR in children and adolescents","volume":"4","author":"Schwartz","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2022.100534_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2014.126","article-title":"Henoch-Schonlein purpura nephritis in children","volume":"10","author":"Davin","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2022.100534_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320309102747","article-title":"Review: renal protection by inhibition of the renin-angiotensin-aldosterone system","volume":"10","author":"Berl","year":"2009","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"issue":"3","key":"10.1016\/j.xkme.2022.100534_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2215\/CJN.04750908","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2022.100534_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-80-3-342","article-title":"The long-term course of poststreptococcal glomerulonephritis","volume":"80","author":"Baldwin","year":"1974","journal-title":"Ann Intern Med"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952200156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952200156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:24:15Z","timestamp":1762910655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259005952200156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S259005952200156X"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2022.100534","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycophenolate Mofetil for Severe IgA Vasculitis Nephropathy in Children: An Observational Study","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2022.100534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100534"}}